- About
- Organization
- Organization Overview
- Dean’s Office
- Department of Bioengineering and Therapeutic Sciences
- Department of Clinical Pharmacy
- Department of Pharmaceutical Chemistry
- Quantitative Biosciences Institute
- Org Chart
- Research
- Education
- Patient Care
- People
- News
- Events
Soller comments on acetaminophen
By UCSF School of Pharmacy Editorial Staff / Tue Jul 7, 2009
William Soller, PhD, UCSF faculty member and expert on food and drug law and regulations comments on the June 30, 2009 vote of a US Food and Drug Administration (FDA) advisory committee to lower the US maximum over-the-counter dose of acetaminophen and make the current maximum single dose of the drug be available by prescription only. Soller's research on acetaminophen was included as part of the advisory committee's deliberations.
Full story
- FDA Crackdown on Acetaminophen [link defunct as of June 10, 2011]
- UCSF Clinical Pharmacy Study Is Part of FDA Acetaminophen Deliberations
More
- FDA Advises Lower Dosage for Popular Painkiller
- June 29-30, 2009: Joint Meeting of the Drug Safety and Risk Management Advisory Committee with the Anesthetic and Life Support Drugs Advisory Committee and the Nonprescription Drugs Advisory Committee Meeting Announcement
- Acetaminophen and Liver Injury: Q&A for Consumers
Tags
Category:
Sites:
School of Pharmacy, Department of Clinical Pharmacy, PharmD Degree Program
About the School: The UCSF School of Pharmacy aims to solve the most pressing health care problems and strives to ensure that each patient receives the safest, most effective treatments. Our discoveries seed the development of novel therapies, and our researchers consistently lead the nation in NIH funding. The School’s doctor of pharmacy (PharmD) degree program, with its unique emphasis on scientific thinking, prepares students to be critical thinkers and leaders in their field.
